Table 1.
Formulation Strategy | Formulation Innovation | Imaging Probe | Imaging Technique | Application | Tests | Ref. |
---|---|---|---|---|---|---|
Chemical modification, prodrugs and bio-precursors | Insertion of a deuterium atom in [18F]fluoromethyl-PBR28 |
18F | PET | Detection of inflammation associated to TSPO overexpression; diagnosis of neuroinflammation, neurodegeneration, and tumor progression | In vitro: human leukocyte membranes and rat cerebrocortical samples; Ex vivo: ICR mice In vivo: rat models of LPS-induced inflammation and of experimental autoimmune myocarditis |
[24,25] |
Fluorine-substituted TSPO ligand | 18F | PET | Detection of neuroinflammation, neurodegeneration, and tumor progression | Ex vivo: ICR mice In vivo: U87-MG xenografted Balb/c nu/nu mice |
[17] | |
Use of buffers | Use of lactate buffer for [18F]F-DOPA dissolution |
18F | PET | Detection of loss of functional dopaminergic neuron terminals in the striatum | In vitro: mouse skeletal muscle fibers In vivo: Wistar rats and C57BL/6J mice |
[26] |
Conjugates for active targeting | Synthesis of dextran-based multifunctional ligands |
99mTc | Lymphoscintigraphy | Sentinel lymph node detection for diagnosis of different types of cancers | In vitro: stability monitored in saline or serum | [27] |
Conjugation of an albumin derivative with a DOTA ring | 177Lu, 111In, 64Cu | PET | Radio-guided occult lesion localization | In vivo: female adult rats | [28] | |
Conjugation of a VCAM-1-binding peptide with a DOTA ring; development of a biotin/avidin three-step pretargeting system based on the same VCAM-1-binding peptide | 68Ga | PET | Early diagnosis of atherosclerosis | In vitro: TNF-α activated HUVEC | [29,30] | |
Conjugation of curcumin with a DOTA ring | 68Ga | PET | Detection of colorectal cancer | In vitro: HT29 colorectal cancer cells In vivo: HT29 tumor-bearing mice |
[31] | |
Nanoparticles | PAMAM dendrimer encapsulating sorafenib | FITC | Fluorescence optical imaging |
Detection and treatment of liver cancer overexpressing ASGPR2 | In vitro: HepG-2 human liver cancer cells | [32] |
PEG-decorated SLNs encapsulating Pt(IV)-prodrugs | Carbon dots | Fluorescence optical imaging |
Assessment of BBB permeability | In vitro: hCMEC/D3 cells and polarized hCMEC/D3 endothelial cells seeded on a porous membrane (BBB model) | [33] | |
PLGA-TSPO NPs | FITC | Fluorescence optical imaging |
Subcellular targeting and imaging of TSPO-overexpressing cells | In vitro: rat C6 glioma cells | [34] | |
TSPO-dextran nanogel | FITC | Fluorescence optical imaging |
Subcellular targeting and imaging of TSPO-overexpressing cells | In vitro: rat C6 glioma cells | [35] | |
PAMAM dendrimer | FITC | Fluorescence optical imaging |
Detection of tumors or neurodegenerative diseases associated to TSPO overexpression | In vitro: C6 rat glioma cells | [36] | |
Silica shell functionalized QDs | QDs | Fluorescence optical imaging |
Detection of tumors or neurodegenerative diseases associated to TSPO overexpression | In vitro: C6 rat glioma cells | [37] | |
USPIONs | Cyanine 5.5 fluorescent dye | NIR optical imaging | Detection of glioblastoma exploiting TSPO targeting | In vitro: U87-MG glioblastoma cells and PC3 prostate cancer cells In vivo: Balb/c athymic mice |
[38] | |
ECFC cells encapsulating AuNPs | AuNPs | PA imaging | Detection and treatment of cancer | In vitro: stack of chicken breast muscle Ex vivo: mouse melanoma, liver and spleen In vivo: CD1 immunodeficient mice |
[39] | |
Chitosan nanobubbles | Gd(III)-DOTP complex | MRI | Detection and treatment of cancer | In vitro: preliminary evaluation of US properties in agar gel suspension | [40] | |
Fe-B NPs enveloped by polyvinylpyrrolidone | Iron | MRI | Optimization of NCT procedures for cancer treatment | In vitro: L929 fibroblasts, 4T1 mammary carcinoma cells and B16 melanoma cells In vivo: Balb/c mice | [41] | |
Iron-doped hydroxyapatite NPs | Iron | MRI coupled to SPECT and/or PET | - | In vivo: C57BL/6 mice | [42] | |
PLGA-PEG micelles encapsulating QDs | QDs | MRI | Detection of inflammatory bowel disease by MAdCAM-1 targeting | In vitro: SKBR3 cells In vivo: C57BL/6 mice |
[43] | |
Carboxymethylcellulose NPs | 68Ga | PET | White blood cells imaging | In vitro: human leukocytes | [44] | |
SiNPs | 99mTc | SPECT | Detection of HER2-positive breast cancer | In vitro: SK-BR-3 cells Ex vivo, in vivo: SK-BR-3 tumor-bearing mice |
[45,46] | |
Fe3O4 NPs | Fe3O4 and 7-nitrobenzofurazan fluorescent dye | Optical imaging/MRI | Detection and treatment of cancer | In vitro: preliminary evaluation of fluorescence and MRI properties | [47] | |
SiNPs embedding dye-modified Au NPs | IRDye 800CW and AuNPs | US/PA imaging | Detection and treatment of cancer | Ex vivo: chicken breast samples | [48] | |
Au-Fe nanoalloys | Au and Fe | X-ray CT/MRI | - | In vivo: Balb/c mice | [22] |